60 Degrees Pharmaceuticals partners with Tulane to study lyme treatment

Go back to 60 Degrees Pharmaceuticals partners with Tulane to study lyme treatment
(NASDAQ: SXTP) Delayed: 1.20 +0.01 (0.84%)
Previous Close $1.19    52 Week High
Open $1.20    52 Week Low
Day High $1.20    P/E N/A 
Day Low $1.20    EPS
Volume 417       

(NASDAQ: SXTPW) Delayed: 0.03 --0 (-0%)
Previous Close $0.03    52 Week High
Open $0.03    52 Week Low
Day High $0.03    P/E N/A 
Day Low $0.03    EPS
Volume 1,508